Surgical Imaging System Articles & Analysis

Earlier this month nView medical (http://www.nviewmed.com/) and the Laboratory for Computational Sensing and Robotics at Johns Hopkins University (http://lcsr.jhu.edu/) entered a joint research agreement to integrate optical technology into nView medical's real-time surgical imaging system. nView medical's mission is to provide the most precise information during surgical procedures to improve ...

By nView medical Inc.

Mid Atlantic Bio Angels (MABA) announces today that it has made an investment in Boston-based New View Surgical., which has developed a proprietary surgical imaging system for laproscopic surgery. This is the eighth investment made by MABA since its founding. “Laproscopic and minimally invasive surgeries have become the norm, and it is important that physicians have the most updated ...

By New View Surgical

nView medical, a Salt Lake City, Utah based medical imaging company installs its 3D surgical imaging system at Johns Hopkins Bayview Medical Center. A team of surgeons and scientific researchers gathered to review the technology and outline upcoming research. “Most computer assisted intervention solutions use pre-operative 3D data and/or intra-operative 2D imaging. nView medical ...

By nView medical Inc.

New View Surgical, Inc., an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery, announced that it closed its Series A Financing Round at $2.5 million. The financing was over-subscribed due to investor demand. New View Surgical will deploy the financing to complete the development of its VisionPort™ System, expand the ...

By New View Surgical

New View Surgical, Inc. an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery, was recognized as one of the top three ‘Most Valued Company’ at the Keiretsu Forum Investor Capital Expo that is showcasing 36 late-stage growth companies seeking funding. Nearly 50 angel groups, investors from 100+ Family Offices, corporate ...

By New View Surgical

OnLume has received 510(k) clearance from the U.S. Food & Drug Administration (“FDA”) to market its first product, a fluorescence guided surgery (FGS) system. The OnLume Imaging System is indicated for fluorescence imaging of blood flow and tissue perfusion before, during, and after vascular, gastrointestinal, organ transplant, plastic, reconstructive, and micro surgeries. This ...

By OnLume Inc.

OnLume Inc., a medical device company developing novel surgical imaging technology, was accepted into the SBIR Advance program sponsored by the Center for Technology Commercialization (CTC). The SBIR Advance program was created by the Wisconsin Economic Development Corporation (WEDC) to provide state match funding, training, and other resources to Wisconsin businesses to advance the ...

By OnLume Inc.

New View Surgical, Inc., a medical device company developing proprietary imaging and access technologies for minimally invasive surgery (MIS), announced today that it received 510(k) clearance from the U.S. Food and Drug Administration for its VisionPort™ System. The VisionPort™ imaging and access system simplifies laparoscopic procedures for hospitals and provides surgeon-controlled ...

By New View Surgical

Gières (Grenoble), France, June 17, 2021 - eCential Robotics, a French growth company that designs, manufactures and markets the first unified 2D/3D robotic imaging and surgical navigation system for bone surgery indications, unveiled its surgical robotic arm as a world premiere at the annual meeting of the French Society of Spinal Surgery (SFCR), which is being held from June 17 to ...

By eCential Robotics

Synaptive Medical, a leader in robotic surgical and imaging technologies, announced today the company has established a partnership with O-Two Medical Technologies, Inc., a world leader in controlled ventilation, for the production of O-Two’s e700 portable transport ventilator for patients impacted worldwide by COVID-19. As part of the agreement, Synaptive will leverage its expertise in ...

By Synaptive Medical

Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, and nView medical, a Salt Lake City-based company developing surgical imaging and guidance systems enabled by artificial intelligence (AI), today announced a partnership and investment agreement to jointly develop and co-market the innovative nView systems with Orthofix cervical spine and ...

By nView medical Inc.

Augmedics, a pioneer in augmented reality surgical image guidance, announced today that it has raised $36 million in an over-subscribed Series C financing with an international syndicate of Israel-US investors. This comes only eight months after the company closed a $21 million Series B financing, bringing the total funding to date to $63 million. H.I.G. Capital, Revival Healthcare Capital, and ...

By Augmedics

First and only image-guided, heat-free surgical robotic procedure aims to establish a new standard of care for patients with enlarged prostates REDWOOD CITY, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it now has five ...

By PROCEPT BioRobotics Corporation

REDWOOD CITY, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced positive five-year results from its 181 patient randomized WATER study comparing Aquablation therapy to TURP, the historical standard of care for treating BPH. WATER ...

By PROCEPT BioRobotics Corporation

OnLume Inc., a medical device company developing novel surgical imaging technology, today announced support from the Small Business Innovation Research (SBIR) program to accelerate work on a fluorescence image-guided surgery (FIGS) system. OnLume received the $300,000 Phase I SBIR grant through the National Cancer Institute (NCI) at the National Institutes of Health (NIH) for the development of ...

By OnLume Inc.